Success Metrics

Clinical Success Rate
100.0%

Based on 24 completed trials

Completion Rate
100%(24/24)
Active Trials
7(21%)
Results Posted
13%(3 trials)

Phase Distribution

Ph phase_1
7
21%
Ph phase_4
4
12%
Ph phase_3
6
18%

Phase Distribution

7

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
7(41.2%)
Phase 3Large-scale testing
6(35.3%)
Phase 4Post-market surveillance
4(23.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.0%

24 of 25 finished

Non-Completion Rate

4.0%

1 ended early

Currently Active

7

trials recruiting

Total Trials

33

all time

Status Distribution
Active(7)
Completed(24)
Terminated(1)
Other(1)

Detailed Status

Completed24
Recruiting5
Active, not recruiting2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (41.2%)
Phase 36 (35.3%)
Phase 44 (23.5%)

Trials by Status

completed2473%
withdrawn13%
active_not_recruiting26%
recruiting515%
unknown13%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT06613854Phase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Recruiting
NCT07271251Phase 3

A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes

Active Not Recruiting
NCT07390110

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

Active Not Recruiting
NCT04596631Phase 3

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Completed
NCT07225816Phase 1

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Recruiting
NCT04707469Phase 3

Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes

Completed
NCT04559815

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice

Completed
NCT06269120

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Recruiting
NCT05035095Phase 3

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

Completed
NCT05443568

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice

Completed
NCT05230589

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice

Completed
NCT05230615

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

Completed
NCT04601753

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice

Completed
NCT04601740

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice

Completed
NCT04862923

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice

Completed
NCT04878393

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice

Completed
NCT04537637

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice

Completed
NCT07056803

Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus

Completed
NCT06659718

Emulation of the SOUL Diabetes Trial in Healthcare Claims

Completed
NCT06003153Phase 4

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
33